Status:

SUSPENDED

Repeatability, Reproducibility and Comparison of Cirrus OCT, RTVue OCT, MS-39 OCT, and Insight 100 VHFDU

Lead Sponsor:

London Vision Clinic

Collaborating Sponsors:

Carl Zeiss Meditec AG

Conditions:

Corneal Thickness Measurement

Epithelial Thickness Measurement

Eligibility:

All Genders

21-70 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the repeatability and reproducibility of corneal, epithelial, and LASIK flap thickness using the Carl Zeiss Meditec Cirrus HD OCT 5000, Optovue RTVue OCT, CSO ...

Detailed Description

Very high-frequency (VHF) digital ultrasound was first used in 1993 to obtain images and measure the thickness of the cornea (the window at the front of the eye) and the layers within the cornea, such...

Eligibility Criteria

Inclusion

  • Only patients who are medically suitable for corneal laser refractive surgery can be included in the study.
  • As general inclusion criteria the following aspects are defined:
  • Subjects should be 21 years of age or older.
  • Contact lens wearers must stop wearing their contact lenses at least four weeks per decade of wear before baseline measurements in case of hard contact lenses and one week before baseline measurements in case of soft contact lenses.
  • Patient will be able to understand the patient information and willing to sign an informed consent.
  • For the normal eye populations:
  • Eyes with no ocular pathology
  • Eyes with no previous ocular or corneal surgery
  • For the post-op eye populations:
  • • Eyes between 3 and 9 months after LASIK or SMILE

Exclusion

  • Previous ocular or corneal surgery (for normal eyes)
  • Patient not being able to tolerate local or topical anesthesia
  • Patient has active conjunctivitis or any active ocular infection or inflammation
  • Patient has a corneal ulcer
  • Patient has an open wound on the corneal epithelium
  • Patient has compromised epithelium (e.g. ≥Grade 3 superficial punctate keratitis)
  • Pregnancy

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

242 Patients enrolled

Trial Details

Trial ID

NCT03473847

Start Date

September 1 2022

End Date

December 1 2023

Last Update

April 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

London Vision Clinic

London, United Kingdom, W1G 7LA